Rachel Kuperman
Overview
Explore the profile of Rachel Kuperman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rao C, Kuperman R
J Child Neurol
. 2024 Aug;
39(11-12):425-432.
PMID: 39175400
Childhood absence epilepsy is one of the most prevalent pediatric epilepsy syndromes, but diagnostic delay is common and consequential. Childhood absence epilepsy is diagnosed by history and physical examination including...
2.
Slavotinek A, Rego S, Sahin-Hodoglugil N, Kvale M, Lianoglou B, Yip T, et al.
NPJ Genom Med
. 2023 Oct;
8(1):34.
PMID: 37872195
No abstract available.
3.
Slavotinek A, Rego S, Sahin-Hodoglugil N, Kvale M, Lianoglou B, Yip T, et al.
NPJ Genom Med
. 2023 May;
8(1):10.
PMID: 37236975
The diagnostic yield of exome sequencing (ES) has primarily been evaluated in individuals of European ancestry, with less focus on underrepresented minority (URM) and underserved (US) patients. We evaluated the...
4.
Macdonald-Laurs E, Sharpe C, Nespeca M, Rismanchi N, Gold J, Kuperman R, et al.
Arch Dis Child Fetal Neonatal Ed
. 2020 Sep;
106(2):162-167.
PMID: 32928896
Objective: Prolonged continuous video-electroencephalography (cEEG) is recommended for neonates at risk of seizures. The cost and expertise required to provide a real-time response to detected seizures often limits its utility....
5.
Sattar S, Kuperman R
Epilepsy Behav
. 2020 Aug;
111:107282.
PMID: 32759065
Telehealth's first literature reference is an article in 1879 in the Lancet about using the telephone to reduce unnecessary office visits (Institute of Medicine & Board on Health Care Services,...
6.
Sharpe C, Reiner G, Davis S, Nespeca M, Gold J, Rasmussen M, et al.
Pediatrics
. 2020 May;
145(6).
PMID: 32385134
Background And Objectives: There are no US Food and Drug Administration-approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of...
7.
Sharpe C, Davis S, Reiner G, Lee L, Gold J, Nespeca M, et al.
J Clin Neurophysiol
. 2018 Oct;
36(1):9-13.
PMID: 30289769
Purpose: Continuous video electroencephalography (cEEG) monitoring is the recommended gold standard of care for at-risk neonates but is not available in many Neonatal Intensive Care Units (NICUs). To conduct a...
8.
Koc G, Sugimoto S, Kuperman R, Kammen B, Karakas S
Pediatr Radiol
. 2016 Sep;
47(1):39-45.
PMID: 27639993
Background: Pancreatic neuroendocrine tumors are not included in the diagnostic criteria for tuberous sclerosis complex, although an association has been described. Objective: To investigate the association of pancreatic neuroendocrine tumor...
9.
Franz D, Belousova E, Sparagana S, Bebin E, Frost M, Kuperman R, et al.
PLoS One
. 2016 Jun;
11(6):e0158476.
PMID: 27351628
Background: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has demonstrated efficacy in treating subependymal giant cell astrocytomas (SEGAs) and other manifestations of tuberous sclerosis complex (TSC). However, long-term use...
10.
Franz D, Belousova E, Sparagana S, Bebin E, Frost M, Kuperman R, et al.
Lancet Oncol
. 2014 Dec;
15(13):1513-1520.
PMID: 25456370
Background: In the EXIST-1 trial, initiated on Aug 10, 2009, more than 35% of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex had at least 50%...